Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

72

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Beta cells intrinsically sense and limit their secretory activity via mTORC1-RhoA signaling

Beta cells intrinsically sense and limit their secretor...

201

Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity

Aspirin prevents metastasis by limiting platelet TXA2 s...

120

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

Cancer-induced nerve injury promotes resistance to anti...

112